Puma Biotechnology Says Online JAMA Oncology Publishes Its NEfERT-T Stage 2 Trial
April 14, 2016 at 12:51 PM EDT
Puma Biotechnology Inc (NYSE: PBYI) disclosed the results of its NEfERT-T Phase two clinical study were published online in JAMA ...